NFE2L2 and NQO1 expression were reduced in striatum in MPTP-treated mice; and NFE2L2 mediated ARE activation was sufficient to produce detoxification enzymes in brain nigrostriatal dopaminergic pathway in rodent PD model [14, 15]. This evidence concerns the gene NFE2L2 and Parkinson disease.